Clinical Trial: CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)

U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06822881) titled 'CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)' on Feb. 07.

Brief Summary: A Clinical Study Exploring CT1190B in the treatment of patients with moderate to severe refractory systemic lupus erythematosus (SLE) or refractory/progressive systemic sclerosis (SSc)

Study Start Date: Feb. 20

Study Type: INTERVENTIONAL

Condition: Systemic Lupus Erythematosus (SLE) Systemic Sclerosis (SSc)

Intervention: DRUG: CAR-T Therapy

CT1190B cells infusion

Recruitment Status: RECRUITING

Sponsor: Beijing GoBroad Hospital

Information p...